
In this episode, Richard Hanbury of Sana Health discusses the company’s recent FDA De Novo clearance for a novel audio‑visual neuromodulation device targeting neuropathic pain, marking the creation of a new therapeutic class. He outlines decades of research that led to pivotal trial data showing reduced reliance on pain medication, and highlights ongoing Department of Defense PTSD studies, VA trials, and expansion into Israel. Hanbury emphasizes that credibility in healthcare is built incrementally and argues for multimodal, scalable approaches to pain and mental health care.

The episode provides an overview of the current Medicare Advantage (MA) landscape, highlighting regulatory changes, enrollment trends, and financial pressures facing insurers. It examines challenges such as rising cost of care, tighter network requirements, and the impact of the Medicare...
In this episode of the "No Market" series, host Stacey Richter talks with Dr. Jacob Asher, a former chief medical officer for major health plans, about why commercial carrier marketplaces—especially in California—are stagnant and lack true competition. They identify six...
In this brief clip, host David Williams talks with Dr. Sarah Matt about the critical role of explainability in building trust for AI-driven healthcare. Dr. Matt emphasizes that patients and providers must understand how AI models make decisions to feel...

In this third episode of his four‑part series, Roger Whitney guides listeners through practical ways to lower health‑care costs before Medicare, from daily health habits to smart insurance shopping. He demystifies the ACA premium subsidy system now that the expanded...
In this 16‑minute DDW Highlights episode, host Bruno Quinney recaps five major drug‑discovery stories from the past week, focusing on a breakthrough study linking specific biomarkers to improved cancer survival rates and the launch of a multinational consortium tackling chronic...
Dave Newman, MD, Chief Medical Officer of Virtual Care at Sanford Health, explains how the system’s expansive virtual care program—spanning 78 specialties across 300,000 square miles—has become essential for rural patients, saving them an average of 176 miles per visit....

In this episode Ryan Morrissey breaks down the essentials of Medicare for listeners approaching age 65, covering Parts A, B, C, and D, associated costs, and the critical timing of enrollment to avoid penalties. He explains the differences between original...

In this episode, a16z partner Jorge Conde interviews Novartis CEO Vasant Narasimhan about reshaping the 250‑year‑old conglomerate into a focused medicines company, a move he estimates will unlock $180 billion of value. Narasimhan outlines Novartis’s three platform pillars—cell and gene therapies,...

In the inaugural episode, host Alex discusses the GLP‑1 business model with obesity expert Prof. Alex Miras, who emphasizes that the drug itself drives the bulk of weight loss—about 20% versus 2.5% from behavioral support—making extensive multidisciplinary care unnecessary for...

In this live conversation, Dr. Bob Wachter and Dr. Lucy McBride discuss the fragmented state of electronic medical records (EMRs) and how patients and physicians alike are overwhelmed by multiple, non‑communicating digital portals. They highlight federal efforts to create standardized, interoperable...

In this fireside chat, Sami Inkinen, CEO and founder of Virta Health, explains how his personal pre‑diabetes diagnosis inspired the creation of a company that uses nutrition, technology and AI to reverse type‑2 diabetes and obesity. He describes Virta’s massive...

The episode opens with a celebration of Women in Science Day, highlighting the historic origin of the term “scientist” and the push for greater female leadership in biotech. Medra CEO Michelle Lee discusses how the company is merging robotics with...
In episode 500 of the Relentless Health Value podcast, host Stacey Richter celebrates the community of healthcare entrepreneurs, executives, and change‑makers she calls the "tribe," highlighting how the show has moved listeners from theory to real‑world transformation. Listener clips illustrate...

In this episode, Gabriele Corso and Jeremy Wohlwend discuss how structural biology has moved beyond AlphaFold's single‑chain predictions toward modeling complex interactions and generative protein design with their open‑source Boltz suite (Boltz‑1, Boltz‑2, and BoltzGen). They explain that evolutionary co‑variation...

In this episode of The Retirement Answer Man, Roger Whitney walks listeners through the three primary health‑care options available before Medicare eligibility: COBRA continuation coverage, ACA marketplace plans, and part‑time employer group insurance, while also noting other alternatives like private...
The episode explores EnGene's experimental gene therapy, detalimogene, for treating non‑muscle invasive bladder cancer, a condition affecting half a million new patients annually. Ron Cooper, EnGene's CEO, explains how the therapy uses a non‑viral vector to deliver a dual payload...
In this 15‑minute episode, DDW host Bruno Quinney recaps five major stories from the past week, highlighting breakthrough cancer therapies that promise greater efficacy and safety, and new research aimed at enhancing brain function in Alzheimer’s patients. He also touches...
In this episode, Michael Carr, VP and CIO of Health First, discusses the organization’s integrated payer‑provider platform built on Epic’s suite, including the provider rollout and the Epic Tapestry health‑plan implementation. He highlights how consolidating nine disparate systems into a...

In this episode, host John Driscoll talks with sports‑medicine physician Dr. Jordan Metzl about why regular exercise is the most effective "drug" for extending healthspan, outpacing the myriad longevity supplements and hacks on the market. Dr. Metzl explains how strength...